State of the art: practical evaluation and management of malignant pleural effusion

PURPOSE OF REVIEW: Malignant pleural effusion (MPE) is associated with substantial symptom burden and limited survival. Recent advances in pleural interventions, molecular diagnostics and prognostic tools are challenging traditional approaches to management. This review summarizes recent developments and considers how these may support more personalised care. RECENT FINDINGS: Indwelling pleural catheters (IPCs) and talc pleurodesis remain the principal definitive treatment strategies, with increasing evidence supporting individualized selection according to lung expandability, prognosis, treatment burden and patient preference. Accelerated diagnostic and therapeutic pathways may reduce repeated procedures. The RED score may help estimate time to further pleural intervention, pending broader validation and evaluation of clinical utility. Patient-reported outcomes and treatment burden are increasingly recognized as important measures of treatment success. SUMMARY: MPE management should integrate tumour biology, pleural physiology, prognosis and patient preferences. Emerging diagnostic, prognostic and technological advances may further enable personalized, patient-centred care.

Authors

Institutions

Publication Details

Journal
Current Opinion in Pulmonary Medicine
Published
2026-11-16
DOI
https://doi.org/10.1097/mcp.0000000000001323
Primary Topic
Pleural and Pulmonary Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

State of the art: practical evaluation and management of malignant pleural effusion

Nick Maskell, Steven Walker, Farah Shiham
Current Opinion in Pulmonary Medicine
Pleural and Pulmonary Diseases
article

State of the art: practical evaluation and management of malignant pleural effusion

Nick Maskell, Steven Walker, Farah Shiham
article en

Abstract

PURPOSE OF REVIEW: Malignant pleural effusion (MPE) is associated with substantial symptom burden and limited survival. Recent advances in pleural interventions, molecular diagnostics and prognostic tools are challenging traditional approaches to management. This review summarizes recent developments and considers how these may support more personalised care. RECENT FINDINGS: Indwelling pleural catheters (IPCs) and talc pleurodesis remain the principal definitive treatment strategies, with increasing evidence supporting individualized selection according to lung expandability, prognosis, treatment burden and patient preference. Accelerated diagnostic and therapeutic pathways may reduce repeated procedures. The RED score may help estimate time to further pleural intervention, pending broader validation and evaluation of clinical utility. Patient-reported outcomes and treatment burden are increasingly recognized as important measures of treatment success. SUMMARY: MPE management should integrate tumour biology, pleural physiology, prognosis and patient preferences. Emerging diagnostic, prognostic and technological advances may further enable personalized, patient-centred care.

Current Opinion in Pulmonary Medicine
University of Bristol (GB)
Good health and well-being
Pleural and Pulmonary Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon